Dry Eye Disease
📧 Sign up to get email alerts when something new happens for Dry Eye Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens Syndrome [Phase 3]
Phase 3 clinical trial update evaluating oral pilocarpine for the treatment of dry eye in patients with Sjögren's syndrome has completed.
-
FDA approval · 2020-06-04FDA Approved: XIIDRA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Xiidra (lifitegrast) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: IVIG-eye Drops Treatment for Dry Eye Disease [Phase 1, Phase 2]
Phase 1/2 clinical trial update on IVIG-eye drops for dry eye disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD) [Phase 1, Phase 2]
Phase 1/2 trial of brimonidine eye drops for ocular graft-vs-host disease and dry eye has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Intense Pulsed Light Study for Dry Eye Disease [NA]
A completed clinical trial investigating intense pulsed light for chronic dry eye disease with results posted in 2019.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2019-09-20FDA Approved: CEQUA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Cequa (cyclosporine ophthalmic solution) from Sun Pharmaceutical Industries. The action upda…
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Effect of Preservative-free Low-dose Hyaluronic Acid-containing Salt Solution on Dry Eye Disease [Phase 4]
Phase 4 trial investigating preservative-free low-dose hyaluronic acid-containing salt solution for dry eye disease.
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease [Phase 3]
Phase 3 trial evaluating OmegaD Softgels for dry eye disease has been completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye [Phase 3]
A Phase 3 trial assessing safety and efficacy of MIM-D3 ophthalmic solution for dry eye has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Clinical Efficacy of Topical Hydrocortisone 0.335% (Softacort®) in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation [Phase 4]
Phase 4 clinical trial evaluating topical hydrocortisone 0.335% (Softacort) for efficacy in chronic dry eye disease with ocular surface infl…
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects. [Phase 1]
Phase 1 study comparing safety and tolerability of the ophthalmic gel PRO-167 to Corneregel in healthy subjects with dry eye conditions; stu…
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects [Phase 1]
Phase 1 trial comparing safety and tolerability of PRO-087 to Xyel Ofteno® and Systane Ultra® on the ocular surface in healthy subjects; com…
-
CLINICAL_TRIALS withdrawal · 2019-05-17Clinical Trial Update: Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease [Phase 4]
A Phase 4 clinical trial investigating the effects of Xiidra on closed-eye tear film leukocytes in dry eye disease was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: A Study to Assess the Safety and Effectiveness of SJP-0035 for the Treatment of Patients With Dry Eye Disease [Phase 3]
Phase 3 trial update for SJP-0035 in dry eye disease completed.
-
CLINICAL_TRIALS trial_result · 2019-04-05Clinical Trial Update: Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease [Phase 2]
Phase 2 clinical trial update for AGN-223575 ophthalmic suspension in dry eye disease, reporting safety, efficacy, tolerability, and pharmac…
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Clinical Study to Evaluate the Efficacy of Ectoin® Containing Eye Spray for Treatment of Dry Eye Disease [NA]
A completed clinical study evaluated the efficacy of Ectoin-containing eye spray for dry eye disease. The trial (NCT03519815) was conducted …
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED) [Phase 3]
Phase 3 double-masked trial of SYL1001 for Dry Eye Disease has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease [NA]
A completed clinical trial evaluated intense pulsed light treatment with meibomian gland expression for dry eye disease. Results were posted…
-
CLINICAL_TRIALS research · 2019-01-24Clinical Trial Update: Correlation of Noninvasive Tear Film Function and the Optical Quality in Mild and Moderate Dry Eye [NA]
This clinical trial study investigates the relationship between noninvasive tear film function and optical quality in individuals with mild …
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca [Phase 2, Phase 3]
A phase 2/3 dose-ranging trial evaluated the safety and efficacy of OTX-101 for keratoconjunctivitis sicca (dry eye disease); the study has …
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: Use of 5.0% Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease in Contact Lens Wearers [Phase 4]
A Phase 4 trial investigating 5.0% lifitegrast ophthalmic solution for dry eye disease in contact lens wearers has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease [Phase 2]
Phase 2 clinical trial evaluating P-321 ophthalmic solution vs placebo in dry eye disease was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2018-09-05Clinical Trial Update: Clinical Evaluation of Systane® Balance in Dry Eye Subjects [NA]
Clinical trial update for Systane Balance in dry eye subjects; study terminated with results posted in 2018.
-
FDA approval · 2018-08-14FDA Approved: CEQUA — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved CEQUA (cyclosporine ophthalmic solution) from Sun Pharmaceutical Industries as an original NDA for the treatment of dry eye dis…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED) [Phase 2]
Phase 2 clinical trial update for CyclASol in moderate to severe dry-eye disease completed with results posted.